KINOS, S.; HAGMAN, H.; HALONEN, P.; SOVERI, L.-M.; O’REILLY, M.; PFEIFFER, P.; FRÖDIN, J.-E.; SORBYE, H.; HEERVÄ, E.; LIPOSITS, G.; KALLIO, R.; ÅLGARS, A.; RISTAMÄKI, R.; SALMINEN, T.; BÄRLUND, M.; SHAH, C.-H. .; MCDERMOTT, R.; RÖCKERT, R.; FLYGARE, P.; KWAKMAN, J.; TESKE, A.; PUNT, C.; GLIMELIUS, B.; ÖSTERLUND, P. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study). Acta Oncologica, [S. l.], v. 63, n. 1, p. 248–258, 2024. DOI: 10.2340/1651-226X.2024.24023. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/24023. Acesso em: 23 jul. 2024.